MesotheliomaPhase 1NCT06885697
TNhYP218 CAR T Cells
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
What the film says
This trial is for adults with non-small cell lung cancer that has a MET exon 14 skipping change.
The idea: combine tepotinib, a daily pill that targets MET, with ivonescimab, an antibody given by vein every three weeks. The study tests up to two doses of tepotinib to find the best one with few or mild side effects.
This phase 1 study plans 16 patients. At Memorial Sloan Kettering Cancer Center in New York, Paul Paik leads it.
Public record; not medical advice.
Sources behind this film
Adults; NSCLC with METex14 skipping; Tepotinib daily pill; ivonescimab IV every 3 weeks; Up to two doses; best dose with few or mild side effects; Phase 1; 16; MSK; Paul Paik
The drug
Tepotinib will be administered at 225mg or 450mg oral daily continuously in every 3 week cycles.
Ivonescimab is administered IV Q3W on Day 1 of each cycle. The total duration of ivonescimab treatment is up to 24 months.
The study
The researchers are doing this study to find out whether the combination of tepotinib and ivonescimab is a safe and effective treatment for people with non-small cell lung cancer (NSCLC) that is positive for METex14 skipping. The researchers will test up to two different doses of tepotinib in combination with ivonescimab to find the best dose of tepotinib that causes few or mild side effects in participants.
Eligibility
Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.
For you, or someone you love
A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.
Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.
Ask about your own file, and walk in with questions for your oncologist or the trial team.
Share one profile with the family helping you, and with your doctors.
Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.